Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 24Fallopian Tube Neoplasms 13Neoplasms 11Breast Neoplasms 11Triple Negative Breast Neoplasms 5Carcinoma, Ovarian Epithelial 5Solid Tumors 4Sarcoma 4Neoplasm Metastasis 4Sarcoma, Ewing 3Lymphoma 3Carcinoma 3Sarcoma, Kaposi 2Rhabdomyosarcoma 2Recurrence 2Osteosarcoma 2Multiple Myeloma 2Lymphoma, T-Cell 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms, Male 2Advanced Solid Tumors 2AIDS-related Kaposi sarcoma 2Urinary Bladder Neoplasms 1Unrecognized Condition 1Subcutaneous panniculitis-like T-cell lymphoma 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Neoplasms 1

Interventions

temsirolimus 2liposomal doxorubicin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Resistant Solid Malignancies × liposomal doxorubicin × Clear all
NCT00703170 2013-05-24

Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies

Washington University School of Medicine

Phase 1 Completed
28 enrolled

Resistant Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡